The Mesothelioma Center News
Recent News Posts
-
news
Asbestos Exposure & BansNew York City Mayor Zohran Mamdani’s administration released more than 170,000 pages of records this week that document air quality conditions around the World… -
news
Treatment & DoctorsU.S. News Names the Best Centers for Mesothelioma Care in 2026
For the twelfth year in a row, U.S. News & World Report named the University of Texas MD Anderson Cancer Center in Houston the… -
news
Legislation & LitigationHome Contractor Exposes Family to Asbestos, Faces Felony Charges
Colorado Attorney General Phil Weiser charged contractor Rocco Roberts with fraud after he allegedly exposed a Boulder family to asbestos during a basement renovation… -
news
Legislation & LitigationJ&J Faces New Lawsuits and Verdicts While Trying to Settle Cases
Johnson & Johnson is facing new legal challenges over its talc products, including a new lawsuit from a Jackson County, Missouri woman. Her lawsuit… -
news
Asbestos Exposure & BansPhiladelphia High School Relocates After Contractor Disturbs Asbestos
The School District of Philadelphia is moving more than 400 students and 90 staff members out of Kensington High School after a contractor disturbed… -
news
Legislation & LitigationUniroyal & Vi-Jon File Chapter 11 Over Asbestos and Talc Claims
Uniroyal Holding Inc. and Vi-Jon, LLC filed for Chapter 11 bankruptcy protection within days of each other, as both companies faced mounting litigation tied… -
news
Research & Clinical TrialsSeeking Mesothelioma Patients for New Cell Therapy Trial
A clinical trial testing a new type of cell therapy for mesothelioma is actively recruiting patients at sites across the country, including Moffitt Cancer… -
news
Legislation & Litigation$5.5B Talc Settlement Offer May End Baby Powder Lawsuits
Johnson & Johnson is proposing a $5.5 billion settlement to resolve approximately 76,000 claims and could close out more than a decade of litigation… -
news
Treatment & DoctorsNew Guidelines Say Surgery Benefits Select Mesothelioma Patients
A national panel of 15 mesothelioma specialists across surgery, medical oncology, radiation oncology and pathology reached a consensus and issued new guidelines for surgery. -
news
Research & Clinical TrialsGene Test May Predict Who Responds to New Mesothelioma Drug
The mesothelioma drug RSO-021 showed promise in an early trial this month. Now the same research team has a lead on who may respond…